The bill establishes the Neurofibromatosis Disease Grant Program within the Florida Department of Health, aimed at advancing research and finding cures for neurofibromatosis. It mandates the awarding of grants for scientific and clinical research, contingent upon legislative appropriation, and outlines the requirements for grant applications. The program will allow any university or established research institute in Florida to submit applications, ensuring equal access for all qualified investigators. Preference will be given to proposals that promote collaboration among institutions and practitioners, and grants will be awarded based on scientific merit through a competitive, peer-reviewed process.

Additionally, the bill stipulates that the Rare Disease Advisory Council and peer review panels must adhere to strict ethical guidelines and conflict of interest policies. Members of these bodies are prohibited from participating in discussions or decisions regarding proposals from entities with which they have a personal or professional connection. The bill also allows for any unspent funds from the General Revenue Fund allocated to the program to be carried forward for up to five years if they are obligated or committed by the end of the fiscal year. The act is set to take effect on July 1, 2026.